Utility of serum soluble mesothelin as a follow-up marker in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
A prospective observational trial examining the value of serum procalcitonin in the diagnosis of pleural infection Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases Year: 2010
Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009
Serum ferritin as a prognostic marker of pneumonia: a prospective, single center study Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions Source: Eur Respir J 2013; 41: 18-24 Year: 2013
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Soluble mesothelin as a monitoring tool for malignant mesothelioma patients Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009
Prospective population-based study on the survival of patients with lung cancer Source: Eur Respir J 2002; 19: 1087-1092 Year: 2002
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Evaluation of gene mutation status and metastasis in lung adenocarcinoma: a multicentric prospective study in Turkey Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019
Female pleural mesothelioma in a French population-based case-control study Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease Year: 2009
Correlation between pleural cytology, radiolgy and histology in mesothelioma: a 3 year retrospective study Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007
Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
The usefulness of Cyfra 21-1 as a disease marker in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006
Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Early symptoms in suspected lung cancer: a prospective cohort study Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001
Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
The role of radial endobronchial ultrasound for peripheral lung cancer tissue sampling and prognostic biomarkers analysis – a single-center retrospective study Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration Year: 2019
Value of neutrophil-to-lymphocyte ratio, procalcitonin, and C-reactive protein in help to predict weaning outcome: a prospective, observational cohort study Source: International Congress 2017 – COPD and weaning Year: 2017
Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019